Chemistry validation
Confirm benzaldehyde selectivity and hydrogen co-production in a laboratory divided cell.
Project Roadmap
From protected concept to industrial validation.
The immediate objective is to generate credible experimental proof, protect the intellectual property, and prepare the technology for an industrial pilot.
Current status
Pre-seed, protected and ready for validation.
The next financing round will fund laboratory work, prototype engineering and recruitment of the core technical team.
Initial reactor concept and system architecture developed
Rotating thin-film electrolysis and paired-chemistry platform defined at a non-enabling level.
Rotating thin-film electrolysis and paired-chemistry platform defined at a non-enabling level.
First commercial application selected
Hydrogen and benzaldehyde co-production identified as the initial validation and market-entry case.
Hydrogen and benzaldehyde co-production identified as the initial validation and market-entry case.
Preliminary process and engineering studies completed
Initial mass and energy balances, development steps and critical proof points established.
Initial mass and energy balances, development steps and critical proof points established.
Priority patent application filed
A priority application has been filed Europe.
A priority application has been filed Europe.
Experimental roadmap prepared
Laboratory chemistry validation, flow-cell screening and rotating thin-film prototype testing planned.
Laboratory chemistry validation, flow-cell screening and rotating thin-film prototype testing planned.
Near-term roadmap
Technical and commercial milestones.
Initial experimental work is planned using relevant laboratory capabilities in Estonia, including potential cooperation with Academic partner.
Prototype development
Design, build and test the first rotating thin-film reactor and compare it with benchmark electrolysis.
Pilot preparation
Integrate product recovery, safety and controls, complete a preliminary TEA and secure an industrial pilot partner.